Park Avenue Securities’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CCM
GCM
RIM
CAM
Park Avenue Securities's LMAT Position: Q2 2024 in Review
Park Avenue Securities sold out of LeMaitre Vascular (LMAT) in Q2 2024, closing a stake of 10,947 shares — an estimated $726K sold.
Park Avenue Securities first reported a position in LMAT in Q3 2022 and held it in 3 quarters. The position peaked at $726K in Q1 2024. 261 funds tracked by Wall St. Rank hold LMAT as of Q2 2024.
- Park Avenue Securities reported no remaining LeMaitre Vascular position as of Q2 2024 after selling out during the quarter.
- Park Avenue Securities sold 10,947 LeMaitre Vascular shares in Q2 2024, an estimated $726K.
- Park Avenue Securities first reported a position in LeMaitre Vascular in Q3 2022 and held it in 3 quarters.
- Park Avenue Securities's LeMaitre Vascular position peaked at $726K in Q1 2024.
- 261 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2024.
Based on Park Avenue Securities's 13F filing for Q2 2024, filed 9 Jul 2024.